Snapshot
- A 42-year-old man with a history of alcohol abuse presents to the clinic with complaints of constant pain at the abdominal region. A physical examination demonstrates a 3-cm mass at the epigastric region. Further laboratory testing shows a persistently elevated serum and urine amylase.
Introduction
- Clinical definition
- describes a circumscribed collection of fluid containing pancreatic enzymes, blood, and necrotic tissue occurring outside the pancreas
- the capsule is a nonepithelialized wall consisting of fibrous granulation tissue
- usually develops within several weeks after the onset of pancreatitis
- describes a circumscribed collection of fluid containing pancreatic enzymes, blood, and necrotic tissue occurring outside the pancreas
- Epidemiology
- demographics
- accounts for approximately 75% of all pancreatic masses
- male predominance, which mirrors the demographic distrubtion seen in pancreatitis
- demographics
- Pathogenesis
- most commonly occurs following acute pancreatitis and abdominal trauma but can also occur due to chronic pancreatitis
- abdominal trauma is the more common cause in children
- can also be single or multiple, though multiple cysts are more frequently seen in patients with alcoholism
- most commonly occurs following acute pancreatitis and abdominal trauma but can also occur due to chronic pancreatitis
- Associated conditions
- acute pancreatitis
- alcoholism
- gallstone
- chronic pancreatitis
- acute pancreatitis
- abdominal trauma
Presentation
- Symptoms
- abdominal pain
- usually with a history of pancreatitis
- anorexia
- indigestion
- nausea
- abdominal pain
- Physical exam
- tender abdomen
- fever
- scleral icterus
- pleural effusion
- peritoneal signs
- if cyst rupture or infection
Imaging
- Abdominal computed tomography (CT) with contrast
- preferred diagnostic test
- positive findings include a well-circumscribed fluid collection that is typically extra-pancreatic with homogenous fluid density with no internal septae
- Magnetic resonance imaging (MRI)
- more sensitive test compared to CT
- allows for better differentiation between pancreatic pseudocyst and other diagnosis (e.g., pseudoaneurysm)
- Endoscopic ultrasound (EUS)
- indicated in patients where the imaging findings or clinical setting is unclear/atypical
- can assess for features suggestive of a cystic neoplasm (e.g., internal septations)
- allows for treatment planning
Studies
- Serum amylase and lipase
- may be normal or elevated
- Serum bilirubin and liver function tests
- may be elevated if there is involvement of the biliary tree
- Cystic fluid analysis
- low levels of carcinoembryonic antigen (CEA) and CEA-125
- low fluid viscosity
- high amylase
Differential
- Cystic neoplasm
- differentiating factors
- MRI can often differentiate between pseudocyst and cystic neoplasm; if the diagnosis is still uncertain, EUS and fine-needle aspiration of the fluid can be performed
- differentiating factors
- cystic fluid analysis will demonstrate high CEA-125, high fluid viscosity, and low amylase
Treatment
- Most pseudocysts resolve without interference and require only supportive care
- First-line
- observation with follow-up imaging every 3-6 weeks
- supportive care
- nasogastric feeding if needed for pain relief
- proton pump inhibitor
- octreotide to reduce pancreatic secretions
- Second-line
- drainage of the pseudocyst is indicated in patients who are symptomatic, have rapidly enlarging pseudocysts, or have complications (e.g., infection of the cyst)
- endoscopic drainage
- preferred method of drainage
- complications include bleeding, performation, and secondary infection
- percutaneous catheter drainage
- higher morbidity, longer hospital stays, and longer duration of indwelling drains compared to endoscopic drainage
- Third-line
- surgery
- indicated in patients with infected pancreatic necrosis and symptomatic sterile necrosis
Complications
- Bleeding/hemorrhage
- erosion of the pseudocyst into a vessel
- GI obstruction
- Pseudocyst rupture
- Peritonitis